Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Kumar Dhanasekharan

Head of Development and Tech Transfer at Amicus Therapeutics


Dr. Dhanasekharan is Head of Biologics Development at Amicus Therapeutics responsible for development and scale-up of biologics of early and late phase programs. Previously, he was responsible for process and analytical development at Cook Pharmica, a contract and development organization (CDMO) in Bloomington, Indiana. Prior to that, he was at Genzyme-Sanofi in various leadership roles including process development, process engineering and manufacturing sciences at Genzyme in Framingham, Massachusetts. He led Quality by Design (QbD) implementation efforts including a lifecycle approach to process validation with process monitoring and control programs. He also led efforts in viral risk mitigation and provided technical leadership for several projects related to Consent Decree remediation.  Kumar has a Ph.D. in Food Science from Rutgers University and a Bachelor's in Chemical Engineering from Indian Institute of Technology, Chennai, India. He has over 50 conference presentations and over 10 peer-reviewed publications.

Agenda Sessions